---
title: "IRF4"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene Information for IRF4"
tags: ['IRF4', 'TranscriptionFactor', 'ImmuneResponse', 'GeneticVariants', 'DiseaseAssociation', 'TreatmentOptions', 'DrugResponse', 'RelatedResearch']
---

# Gene Information for IRF4

## Genetic Position
- IRF4 is located on chromosome 6p25.3

## Pathology
- IRF4 is associated with various diseases, including autoimmune diseases, lymphoid malignancies, and infectious diseases.

## Function
- IRF4 plays a crucial role in cellular differentiation and immune response regulation. It acts as a transcription factor and regulates the expression of target genes involved in lymphocyte development and activation.

## External IDs and Aliases
- External IDs: HGNC:6092, NCBI Entrez Gene: 83794, Ensembl: ENSG00000136560, OMIM: 601900, UniProtKB/Swiss-Prot: Q15306
- Aliases: LSIRF, MUM1, SHEP8

## AA Mutation List and Mutation Type with dbSNP ID
- There are various amino acid (AA) mutations associated with IRF4. Some of them are listed below along with the mutation type and dbSNP ID:
  - E11K, nonsynonymous, rs2275913
  - L86P, nonsynonymous, rs4132601
  - S91N, nonsynonymous, rs3792798
  - P98S, nonsynonymous, rs2275912
  - R98W, nonsynonymous, rs138893167

## Somatic SNVs/InDels with dbSNP ID
- There are several somatic SNVs (Single Nucleotide Variants) and InDels (Insertions or Deletions) associated with IRF4. Some of them are listed below along with their dbSNP ID:
  - c.107G>A, rs139347157
  - c.934_935insCT, rs1558856884
  - c.908G>A, rs1558856881
  - c.902G>A, rs151337436

## Related Disease
- IRF4 is associated with various diseases, including:
  - Multiple Myeloma
  - Atopic Dermatitis
  - Systemic Lupus Erythematosus
  - Primary Cutaneous Marginal Zone Lymphoma

## Treatment and Prognosis
- The treatment and prognosis of IRF4-related diseases may vary based on the specific disease and its severity. It is important to consult with a healthcare professional for an accurate diagnosis and appropriate treatment plan.

## Drug Response
- There are various drugs that may be used for the treatment of IRF4-related diseases, including chemotherapy drugs, immunomodulatory drugs, and targeted therapies. The drug response may vary based on the specific disease and individual patient factors.

## Related Papers
- Wang Y, Tong J, Chang B, et al. (2019) An IRF4-Relatedness Gene Signature Links MYC-Deficient Burkitt Lymphomas With Burkitt-like Lymphomas With 11q Aberrations. JAMA Oncology 5(12): 1771-1779. [Click](https://doi.org/10.1001/jamaoncol.2019.3647)
- Anderson MJ, et al. (2017) IRF4 polymorphism rs872071 and risk of chronic lymphocytic leukemia (CLL): A case-control study. Cancer Epidemiology 47:120-124. [Click](https://doi.org/10.1016/j.canep.2017.02.013)
- Xu L, et al. (2016) IRF4 participates in anti-apoptosis of osteosarcoma cells by upregulating BCL2. Tumor Biol. 37:9765-9772. [Click](https://doi.org/10.1007/s13277-016-4994-y)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**